September 7th 2023
In a recent study, improvements in symptom severity and quality of life scores at years 1, 2, and 3 were seen in patients receiving hysterectomy, myomectomy, or uterine artery embolization.
23rd Annual International Congress on the Future of Breast Cancer® East
Register Now!
7th Annual New York Cardio-Endo-Renal Collaborative (NY CERC)
Register Now!
5th Annual Precision Medicine Symposium: An Illustrated Tumor Board
Register Now!
Clinical Conversations With the Cancer Care Team: Discussing the Impact of Social Inequities on Treatment Outcomes in Triple-Negative Breast Cancer
View More
Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices
View More
Patient, Provider, & Caregiver Connection: Individualizing Care in Multiple Sclerosis – Understanding Patient Challenges and the Role of Innovative Treatment
View More
Expert Illustrations & Commentaries™: Targeting Immune Cells to Treat Multiple Sclerosis
View More
Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies
View More
4th Annual International Congress on the Future of Women’s Health™
View More
Advances In Treating Migraine in Your OB/GYN Practice: Navigating Treatment Paradigms to Improve Patient Care
View More
Does bacterial vaginosis increase risk of developing uterine fibroids?
June 24th 2021No evidence exists that bacterial vaginosis (BV)-associated bacteria increases the risk of developing uterine fibroids (UFs) or the number of UFs, according to a nested case-control study in the journal Sexually Transmitted Diseases.
Read More
Oral supplementation to treat uterine fibroids
May 17th 2021A prospective study has concluded that women of childbearing age with uterine fibroids (UF) who desire to preserve fertility benefit from the combined oral supplementation of vitamin D, epigallocatechin gallate (EGCG) and vitamin B6.
Read More
Radiofrequency ablation of uterine fibroids
April 15th 2021Transcervical fibroid ablation (TFA) to treat symptomatic uterine fibroids (UFs) is effective for a wide range of fibroid types and sizes, according to preliminary results of the first 160 women treated in the Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry (SAGE registry).
Read More
Clinical practice and research yields valuable data for management of uterine fibroids
March 15th 2021“New studies are showing significantly increased risks of cardiovascular disease, weight gain and mood disorders, even with bilateral ovarian conservation,” Elizabeth A. Stewart, MD, told Contemporary OB/GYN.
Read More
Evolving patient evaluation and therapies for uterine fibroids
March 15th 2021When it comes to diagnosing women with uterine fibroids (UFs), no single patient, fibroid or lived experience is the same, according to Sony Sukhbir Singh, MD, a professor of gynecology at the University of Ottawa and The Ottawa Hospital in Ontario, Canada.
Read More
Pathophysiology of uterine fibroids
March 8th 2021A better understanding of the pathophysiology of uterine fibroids (UFs) will enable healthcare providers to deliver high-quality informed care to their patients, according to Ayman Al-Hendy, MD, PhD, a professor of ob/gyn at Pritzker School of Medicine, University of Chicago.
Read More
Pregnancy outcomes for women with large uterine fibroids
February 16th 2021A study in the Journal of Maternal-Fetal and Neonatal Medicine found that the combination of a cervical procedure and vaginal micronized progesterone helped achieve term deliveries in more than 90% of pregnant women with large uterine fibroids (UFs).
Read More
Black women scheduling a uterine-sparing treatment for leiomyomas
February 16th 2021Black women are more likely to undergo uterine fibroid (UF) treatments that are uterine-sparing compared with their White counterparts, according to a prospective cohort study in the Journal of Women’s Health.
Read More
Laparoscopic retrograde hysterectomy in a large uterus
January 19th 2021A retrospective study in the journal Obstetrics & Gynecology and Reproductive Health has concluded that total laparoscopic retrograde hysterectomy (TLreH) for severe endometriosis with obliterated cul-de-sac is both feasible and safe.
Read More
Hysteroscopic myomectomy for submucosal fibroids
January 15th 2021Women with submucosal uterine leiomyomas who undergo hysteroscopic removal have comparable birth outcomes to women with submucosal uterine leiomyomas who do not have hysteroscopic removal, according to a retrospective case-control study in the American Journal of Obstetrics & Gynecology MFM.
Read More
MRI to differentiate uterine leiomyosarcoma from benign leiomyoma
December 31st 2020High signal intensity on T1-weighted magnetic resonance images (MRI) and low diffusion coefficient values can accurately differentiate uterine leiomyosarcoma from benign leiomyoma, according to a meta-analysis in the Journal of the Belgium Society of Radiology.
Read More
Elagolix effective for heavy menstrual bleeding due to uterine fibroids in wide range of women
November 1st 2020“There is a large unmet need in the uterine fibroid space for noninvasive treatment options,” said Ayman Al-Hendy, MD, Ph.D., lead author of the analysis and a professor of ob/gyn at The University of Chicago.
Read More
Ultrasound vs. MRI to detect uterine leiomyomas
October 23rd 2020A prospective observational study in the Journal of Ultrasound in Medicine has concluded that for pretreatment evaluation of uterine fibroids (UF), transabdominal contrast-enhanced ultrasound (CEUS) represents a viable alternative to traditional contrast-enhanced magnetic resonance imaging (MRI).
Read More
FDA: New assessment discourages morcellation for fibroids
December 19th 2017An updated review of evidence by the US Food and Drug Administration (FDA) underscores concerns expressed in 2014 by the agency about use of laparoscopic power morcellators (LPM) for treatment of uterine fibroids. Plus: Prescription habits show ob/gyns not well informed about opioids, according to a study. Also: Does ADHD medication use during pregnancy increase risk of congenital malformations?
Read More